Erin Hunter is an assistant editor at Pharmacy Times®. She is a proud alumna of the University of Massachusetts. She graduated with degrees in Journalism, Art History, and Environmental Conservation.
Clinical Trial Confirms Highest Reported Sensitivity Results for At-Home, Noninvasive Colorectal Cancer Screening Test
The stool-test is the first-of-its-kind to detect CRC in adults aged 45 to 49 years, with a premarket approval submission planned to be sent to the FDA early in 2023.
Bovine Collagen May Preserve, Restore Soft Tissue for Moderately, Heavily Exudating Wounds
Soft tissue reconstruction solutions can leverage a patient’s natural healing response.
Sublingual Ketamine Demonstrated to Be Safe, Effective for Patients with Treatment-Resistant Depression
Research highlights that 6 doses of sublingual ketamine may be more effective than 3 doses, however both can ameliorate symptoms of anxiety and depression.
AI Could Improve Blood Sugar Management in Type 1 Diabetes
An app using AI to evaluate blood sugar data, concerning trends, and recommend management tools will be a part of a clinical trial in 2024 for further assessment.
European Generic Medication Shortages Raise Concerns About US Drug Supply
Energy crisis in Europe puts strain on production and could have ramifications that extend beyond the continent's borders.
FDA Approved IND for CAR T Cell That Target Metastases-Causing Breast Cancer Tumor
The head of the CAR T cell antibody can recognize and target the growth factor in its tumor microenvironment.
FDA Approves Risperidone for Schizophrenia, Bipolar I Disorder
The atypical antipsychotic is an extended-release injectable suspension that is administered bi-weekly.
Expert Suggests That Pharmacists Should Be Learning Primary Palliative Care Skills
“It's an honor to walk the last steps with someone, it is.”-Mary Lynn McPherson, PharmD, MA, MDE, FAAHPM
Case Study Demonstrates Systematic Approach to Increase C. Difficile Cure Rates With Fecal Microbial Transplant
Clostridium difficile is a gram-positive, spore-forming, bacterium that is mainly caused by recent hospitalizations, advanced age, or antibiotic treatments.
Investigational T-cell Therapy for Viral Infections After Allogeneic Stem Cell Transplant Showed 95% Patient Response
Viral infections can plague patients who have undergone stem cell transplantation.
Patients With Inflammatory Disorders May Benefit From Psilocybin Treatment
Psilocybin is derived from certain types of mushrooms and has been proven to affect serotonin receptors.
FDA Approves Albuterol/Budesonide Rescue Medication for Asthma Exacerbations
The drug combination can significantly improve lung function and reduce severe asthma exacerbations.
CDC Approves Mindfulness-Driven Digital Therapeutic for Diabetes Prevention
The new CDC-approved app launched January 1, 2023.
Vitamin D Supplementation Linked to Fewer Cases of Melanoma
In the geographical region of a recent study, data showed melanoma cause high mortality rates in relation to incidence.
Use of Telehealth Services for Mental Health Dramatically Increased in 2020, Offsetting Rapid Decline of In-Person Care
Individuals in metropolitan counties used mental health services more than individuals in rural counties.
Disparity Among Black, White Adults With Uncontrolled Blood Pressure
Black patients aged 18 to 49 years showed a greater association with uncontrolled blood pressure while on an antihypertensive medication.
FDA Grants Priority Review to Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma
If approved, glofitamab will treat the most aggressive type of non-Hodgkin lymphoma.
Hybrid Immunization Can Provide 90% Protection Against Omicron BA.5 Variant
Relative risk calculations show that vaccinated individuals infected with the first Omicron subvariants of COVID-19 could have protection that lasts nearly 3 seasons.
FDA Grants Accelerated Approval to Lecanemab for Early Stage Alzheimer Disease
Lecanemab (Lequembi) approved to treat mild cognitive impairment or mild dementia associated with Alzheimer disease.
AI Can Map Entire Patient Journey in Precision Oncology, From Clinical Trial Matching to Drug Matching
This technology could facilitate equal access to value-based pathways in oncology care and optimize the individual treatment approach.
FDA to Review a Preventative RSV Treatment Developed for Infant Population
The novel antibody will receive expedited review, according to the FDA, and already has market authorization in the European Union.
Physical Activity 3 Times Per Week May Reduce Symptoms of Depression in Children and Adolescents
The benefits of physical activity may be greater for children and adolescents with clinical depression or depressive symptoms, who may develop anxiety and other disorders in adulthood.
Risk of Venous Thromboembolism Worse For Women with Diabetes Mellitus Than Men
A study showed that the risk of developing venous thromboembolism is worse for perimenopausal women with diabetes.
Rare MIS-C Does Not Appear to Impact COVID-19 Vaccine Safety in Children
Children who experienced COVID-19-induced multisystem inflammatory syndrome did not experience severe adverse reactions following COVID-19 vaccination.
Hemophilia B Gene Therapy Significantly Reduces Annual Bleeds in Phase 3 Trial
The FDA granted fidanacogene elaparvovec breakthrough, regenerative medicines advance therapy, and orphan drug designations.
Generic Product News: December
Products include the generic alternatives to Esbriet and Oracea.
Generic, Biosimilar Drugs Generate Record Savings of $373 Billion in 2021
But many patients pay more than necessary because of PBMs, patent abuses, IQVIA data shows.
For the First Time, An Anti-Cancer Vaccine May Be Viable, Effectively Reduce Cancer Risk
An anti-cancer vaccine that is now in clinical trials shows promise as a preventative agent. However, experts are unsure when it will be widely available.
Education by Pharmacist May Help Oncologists Who Are “Drowning in Data”
Lions and tigers and zebras oh my! Expert says precision medicine helps identify unique “zebras” (cancers), but it is increasingly difficult to keep up with new treatment indications across a broad range of cancers.
Zoster-Associated Pain Reduced With Effective Intervention Measures
Associated postherpetic neuralgia risk factors are history of diabetes mellitus, age, and immune-related disease.
2 Clarke Drive Cranbury, NJ 08512